BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30530271)

  • 1. Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application.
    Lambertini M; Horicks F; Del Mastro L; Partridge AH; Demeestere I
    Cancer Treat Rev; 2019 Jan; 72():65-77. PubMed ID: 30530271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.
    Senra JC; Roque M; Talim MCT; Reis FM; Tavares RLC
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):77-86. PubMed ID: 29055060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R).
    Choi MC; Chung YS; Lee JW; Kwon BS; Park BK; Kim SI; Shim SH; Lee KB; Seong SJ; Lee SJ; Lee SH; Yoo HJ; Song T; Kim MK; Baek MH; Kang S; Kim YM
    Eur J Cancer; 2020 Jul; 133():56-65. PubMed ID: 32442924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine prevention of chemotherapy-induced ovarian failure.
    Blumenfeld Z; Evron A
    Curr Opin Obstet Gynecol; 2016 Aug; 28(4):223-9. PubMed ID: 27253235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data.
    Lambertini M; Moore HCF; Leonard RCF; Loibl S; Munster P; Bruzzone M; Boni L; Unger JM; Anderson RA; Mehta K; Minton S; Poggio F; Albain KS; Adamson DJA; Gerber B; Cripps A; Bertelli G; Seiler S; Ceppi M; Partridge AH; Del Mastro L
    J Clin Oncol; 2018 Jul; 36(19):1981-1990. PubMed ID: 29718793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists.
    Blumenfeld Z; Evron A
    Expert Opin Pharmacother; 2015 May; 16(7):1009-20. PubMed ID: 25826240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of gonadal function in women undergoing chemotherapy: a review of the potential role for gonadotropin-releasing hormone agonists.
    Hickman LC; Valentine LN; Falcone T
    Am J Obstet Gynecol; 2016 Oct; 215(4):415-22. PubMed ID: 27422055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies over the use of GnRH agonists for reduction of chemotherapy-induced gonadotoxicity.
    Garrido-Oyarzún MF; Castelo-Branco C
    Climacteric; 2016 Dec; 19(6):522-525. PubMed ID: 27644002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patients.
    Conte B; Del Mastro L
    Minerva Ginecol; 2017 Aug; 69(4):350-356. PubMed ID: 28398024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.
    Lambertini M; Cinquini M; Moschetti I; Peccatori FA; Anserini P; Valenzano Menada M; Tomirotti M; Del Mastro L
    Eur J Cancer; 2017 Jan; 71():25-33. PubMed ID: 27940355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors.
    Blumenfeld Z; Zur H; Dann EJ
    Oncologist; 2015 Nov; 20(11):1283-9. PubMed ID: 26463871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of menopausal symptoms in premenopausal breast cancer patients and current pharmacological prevention strategies.
    Lei YY; Yeo W
    Expert Opin Drug Saf; 2021 Oct; 20(10):1163-1175. PubMed ID: 33951990
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical approaches to preservation of fertility in female cancer patients.
    Del Mastro L; Giraudi S; Levaggi A; Pronzato P
    Expert Opin Pharmacother; 2011 Feb; 12(3):387-96. PubMed ID: 21254946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of gonadal function in women undergoing chemotherapy: a systematic review and meta-analysis of the potential role for gonadotropin-releasing hormone agonists.
    Hickman LC; Llarena NC; Valentine LN; Liu X; Falcone T
    J Assist Reprod Genet; 2018 Apr; 35(4):571-581. PubMed ID: 29470701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials.
    Del Mastro L; Ceppi M; Poggio F; Bighin C; Peccatori F; Demeestere I; Levaggi A; Giraudi S; Lambertini M; D'Alonzo A; Canavese G; Pronzato P; Bruzzi P
    Cancer Treat Rev; 2014 Jun; 40(5):675-83. PubMed ID: 24360817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain.
    Turner NH; Partridge A; Sanna G; Di Leo A; Biganzoli L
    Ann Oncol; 2013 Sep; 24(9):2224-35. PubMed ID: 23709175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.
    Munhoz RR; Pereira AA; Sasse AD; Hoff PM; Traina TA; Hudis CA; Marques RJ
    JAMA Oncol; 2016 Jan; 2(1):65-73. PubMed ID: 26426573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?
    Lambertini M; Richard F; Nguyen B; Viglietti G; Villarreal-Garza C
    Clin Med Insights Reprod Health; 2019; 13():1179558119828393. PubMed ID: 30886529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.
    Demeestere I; Brice P; Peccatori FA; Kentos A; Dupuis J; Zachee P; Casasnovas O; Van Den Neste E; Dechene J; De Maertelaer V; Bron D; Englert Y
    J Clin Oncol; 2016 Aug; 34(22):2568-74. PubMed ID: 27217453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for fertility preservation in young early breast cancer patients.
    Tomasi-Cont N; Lambertini M; Hulsbosch S; Peccatori AF; Amant F
    Breast; 2014 Oct; 23(5):503-10. PubMed ID: 24934638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.